LGND insider trading
Open-market stock trades by Ligand Pharmaceuticals (LGND) executives and directors: who bought or sold, how many shares, at what price and when.
LGND insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | Reardon Andrew | CLO & Secretary | Sell | 833 | $302.51 | $251.99K |
| Oct 2, 2026 | Reardon Andrew | CLO & Secretary | Sell | 1,976 | $303.54 | $599.80K |
| Oct 2, 2026 | Reardon Andrew | CLO & Secretary | Sell | 1,535 | $304.52 | $467.43K |
| Oct 2, 2026 | Reardon Andrew | CLO & Secretary | Sell | 404 | $306.18 | $123.70K |
| Oct 2, 2026 | Reardon Andrew | CLO & Secretary | Sell | 235 | $307.19 | $72.19K |
| Oct 2, 2026 | Reardon Andrew | CLO & Secretary | Sell | 17 | $307.74 | $5.23K |
| Sep 10, 2026 | Zimmermann Martine | director | Sell | 1,200 | $285.00 | $342.00K |
| Sep 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 300 | $283.99 | $85.20K |
| Sep 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 1,800 | $285.17 | $513.30K |
| Sep 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 2,115 | $286.36 | $605.65K |
| Sep 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 385 | $287.53 | $110.70K |
| Sep 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 400 | $288.98 | $115.59K |
| Aug 12, 2026 | Espinoza Octavio | Chief Financial Officer | Sell | 31,641 | $292.06 | $9.24M |
| Aug 12, 2026 | Haas Jason | director | Sell | 7,138 | $292.81 | $2.09M |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 105 | $284.14 | $29.83K |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 33 | $284.55 | $9.39K |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 157 | $285.74 | $44.86K |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 1,032 | $286.80 | $295.97K |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 1,214 | $287.77 | $349.36K |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 356 | $288.75 | $102.79K |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 503 | $289.80 | $145.77K |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 200 | $290.60 | $58.12K |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 991 | $291.71 | $289.09K |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | Sell | 409 | $292.82 | $119.76K |
| Jul 1, 2026 | Reardon Andrew | CLO & Secretary | Sell | 396 | $308.99 | $122.36K |
| Jul 1, 2026 | Reardon Andrew | CLO & Secretary | Sell | 104 | $310.20 | $32.26K |
| Jul 1, 2026 | Reardon Andrew | CLO & Secretary | Sell | 1,119 | $311.72 | $348.81K |
| Jul 1, 2026 | Reardon Andrew | CLO & Secretary | Sell | 1,081 | $312.28 | $337.57K |
| Jul 1, 2026 | Reardon Andrew | CLO & Secretary | Sell | 700 | $313.46 | $219.42K |
| Jul 1, 2026 | Reardon Andrew | CLO & Secretary | Sell | 100 | $314.58 | $31.46K |
| Jul 1, 2026 | Reardon Andrew | CLO & Secretary | Sell | 900 | $315.78 | $284.20K |
| Jul 1, 2026 | Reardon Andrew | CLO & Secretary | Sell | 600 | $317.15 | $190.29K |
| Jun 16, 2026 | Sabba Stephen L | director | Sell | 2,145 | $254.00 | $544.83K |
| Jun 12, 2026 | Haas Jason | director | Sell | 3,000 | $255.01 | $765.03K |
| Jun 12, 2026 | Haas Jason | director | Sell | 3,461 | $256.08 | $886.29K |
| Jun 10, 2026 | Aryeh Jason | director | Sell | 500 | $250.00 | $125.00K |
| Jun 11, 2026 | Aryeh Jason | director | Sell | 4,500 | $250.00 | $1.12M |
| Jun 10, 2026 | LAMATTINA JOHN L | director | Sell | 257 | $247.22 | $63.54K |
| Jun 10, 2026 | LAMATTINA JOHN L | director | Sell | 232 | $248.11 | $57.56K |
| Jun 10, 2026 | LAMATTINA JOHN L | director | Sell | 697 | $249.53 | $173.92K |
- LGND insiders bought $0.00 and sold $21.38M in open-market trades over their last 40 filings.
Updated 2026-11-02 23:13 UTC